Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy

Overview of attention for article published in European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP), July 2016